Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
Subscribe To Our Newsletter & Stay Updated